Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Brain sleepiness signature, links to memory identified

June 19, 2018

Roche patents anti-pY796-DDR1 antibodies

June 8, 2018

Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides

May 8, 2018

Bristol-Myers Squibb presents new TYK2 inhibitors

April 25, 2018

Afecta Pharmaceuticals patents novel hgh mobility group protein B1 inhibitors

April 25, 2018

Novel calpain inhibitors identified at Blade Therapeutics

April 23, 2018

Pliant Therapeutics patents new integrin alphavbeta1 antagonists

April 5, 2018

Genentech and Roche present new HsNIK inhibitors

March 22, 2018

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

March 21, 2018

Lycera patents new Rho-associated protein kinase 1/2 inhibitors

March 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 10, 2025.
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Merck wins approval FDA in pediatric RSV and steps into CDC uncertainty
BioWorld
With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...